Forbes January 18, 2025
Medicare officials announced the selection yesterday of the second round of 15 top-selling prescription drugs for price negotiations, as part of a program established by the Inflation Reduction Act and signed into law by President Biden in 2022. The legislation’s intent is to lower the cost of medications for seniors and disabled folks. The selection of these 15 medications comes just days before President-elect Trump will be inaugurated and his next administration will be in charge of the executive branch, including the Centers for Medicare and Medicaid Services. It’s unknown whether the incoming Trump administration intends to pause or modify the drug price negotiation program, and if it will move ahead with last month’s proposal by the Biden administration to...
Today's Sponsors
Today's Sponsor